The pharmaceutical industries face a series of challenges in the delivery of many newly developed drug molecules because of their low solubility, bioavailability, stability and polymorphic conversion.
This critical review highlights the recent advancements of using biocompatible ionic liquids as “green” designer solvents and/or materials to overcome the limitations caused by conventional organic solvents/materials in pharmaceutics and medicine.